|
B.G. Susan Robinson, Vice President, Business Development
Susan Robinson leads the licensing and partnering activities for Targeted Genetics and is integrally involved in the M&A activities and strategic planning functions for the company. Prior to joining Targeted Genetics in March 2000, Ms. Robinson was employed as Director, Business Development at Genzyme Molecular Oncology , a tracking stock of Genzyme Corporation. In her business development roles she has completed multiple academic and corporate technology licenses, sponsored research agreements, pharma/biotech product development collaboration agreements and an acquisition. Prior to Genzyme, and over a nine year period, Ms. Robinson held increasingly responsible positions in corporate development and Corporate Communications for two biotech companies. In these positions, she was involved in strategic planning, public and private financing efforts, interactions with sell and buyside analysts and the creation and delivery of investor presentations and press releases. Ms. Robinson graduated with a B.S. in Biology from Yale University in 1983. | 